Myofibroma: all 344 studies
Page 1 of 4. Open to participants first (41), then studies with results posted, then the rest; newest registration first within each.
- Artificial Intelligence Into Ultrasound Diagnostics in Reproductive MedicineRecruitingNCT07810920
- Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological SurgeryNot yet recruitingNCT07772076
- Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryNot yet recruitingNCT07746349Not applicable
- Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney CancerNot yet recruitingNCT07716735Phase 1
- Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical TourniquetRecruitingNCT07526311Not applicable
- Ergometrine Versus Carbetocin to Decrease Blood Loss in MyomectomyRecruitingNCT07390864Not applicable
- RCT - Efficacy of Intravenous Vitamin C Versus Placebo on Estimated Blood Loss in Total Abdominal HysterectomyEnrolling by invitationNCT07335432Not applicable
- Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion GelNot yet recruitingNCT07280286Not applicable
- Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and FibroidsEnrolling by invitationNCT07129005
- Effect of Vitamin D3 Supplementation on Symptomatic Uterine Fibroid in Women With Vitamin D DeficiencyRecruitingNCT07012161Early Phase 1
- Fertility Limiting Diseases of Pelvic Organs and Their Influence on Receptivity of Endometrial Cavity: Prospective Clinical TrialRecruitingNCT06991595
- Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn StudyRecruitingNCT06953076
- Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.RecruitingNCT06882824Not applicable
- Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center Observational StudyRecruitingNCT06805019
- Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAERecruitingNCT06705075Phase 2
- Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal HysterectomyRecruitingNCT06658145Not applicable
- Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid AblationNot yet recruitingNCT06640738Phase 4
- Binaural Sound for Remimazolam MaintenanceRecruitingNCT06497283Not applicable
- Clinical Research on the Application of Single-channel Uterine Fibroid Morcellation System in Laparoscopic MyomectomyNot yet recruitingNCT06442605Not applicable
- Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal MyomectomyRecruitingNCT06325501Phase 3
- Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled TrialRecruitingNCT06269809Not applicable
- Risk Factors and A Prediction Model of Recurrence of Uterine FibroidsNot yet recruitingNCT06234670
- Clinical Outcomes of Robotic MyomectomyRecruitingNCT06208891
- Binaural Sound for Remimazolam InductionRecruitingNCT06099977Not applicable
- Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing AgeNot yet recruitingNCT06055114
- Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort StudyRecruitingNCT06009562
- Safety & Efficacy of Non-Invasive Procedures Using Ultrasound-Guided HIFU 'Sonotrip V20' in Symptomatic Uterine FibroidsNot yet recruitingNCT05972642Early Phase 1
- Paracervical Block Versus Transcervical Block in Outpatient Procedural HysteroscopyNot yet recruitingNCT05967936Not applicable
- The Impact of Myomectomy on IVF OutcomesNot yet recruitingNCT05932082Not applicable
- To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or MifepristoneNot yet recruitingNCT05898321Not applicable
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisRecruitingNCT05862272Phase 3
- Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesRecruitingNCT05534854
- Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFURecruitingNCT05500118
- A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine FibroidsRecruitingNCT05442827Phase 2/3
- Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine FibroidsRecruitingNCT05386615
- Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine FibroidsRecruitingNCT05078307Not applicable
- Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With HistologyRecruitingNCT04990076
- Prophylactic Tranexamic Acid During Minimally Invasive MyomectomiesRecruitingNCT04311073Phase 3
- Characterisation of Uterine Fibroid Tissue StiffnessEnrolling by invitationNCT03369600Not applicable
- The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract SymptomsRecruitingNCT02495311
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruitingNCT00005095
- The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine FibroidsTerminatedNCT03993210Not applicableResults posted
- A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03886220Phase 4Results posted
- Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03751124Phase 3Results posted
- LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03412890Phase 3Results posted
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)TerminatedNCT03400956Phase 3Results posted
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)TerminatedNCT03400943Phase 3Results posted
- Treatment of Heavy Menstrual Bleeding in Women With Uterine FibroidsCompletedNCT03317795Phase 4Results posted
- LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03049735Phase 3Results posted
- An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT02925494Phase 3Results posted
- Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of FibroidsCompletedNCT02844920Results posted
- An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsTerminatedNCT02811159Phase 2Results posted
- Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)CompletedNCT02691494Phase 3Results posted
- A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine FibroidsCompletedNCT02655237Phase 3Results posted
- A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine FibroidsCompletedNCT02655224Phase 3Results posted
- Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT02654054Phase 3Results posted
- Symphion® System In-Office StudyCompletedNCT02520414Not applicableResults posted
- Pilot of Letrozole for Uterine MyomasCompletedNCT02470741Phase 4Results posted
- Safety and Effectiveness of OCL 503 in the Treatment of Women With LeiomyomataCompletedNCT02410018Not applicableResults posted
- Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine FibroidsCompletedNCT02323646Phase 2Results posted
- A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine FibroidsCompletedNCT02301897Phase 2Results posted
- Sonography Guided Transcervical Ablation of Uterine FibroidsCompletedNCT02228174Not applicableResults posted
- Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE ProcedureCompletedNCT02227316Phase 4Results posted
- Misoprostol for Reduction of Blood Loss During Fibroid SurgeryTerminatedNCT02209545Phase 4Results posted
- A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147197Phase 3Results posted
- A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With LeiomyomasCompletedNCT02147158Phase 3Results posted
- Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine FibroidsCompletedNCT01946178Not applicableResults posted
- Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)CompletedNCT01817530Phase 2Results posted
- Embozene Microspheres for Uterine Fibroid Embolization (UFE)TerminatedNCT01675011Not applicableResults posted
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01629563Phase 3Results posted
- Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine FibroidsCompletedNCT01451424Phase 2Results posted
- Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine FibroidsCompletedNCT01441635Phase 2Results posted
- MyoSure Hysteroscopic Tissue Removal System Registry StudyCompletedNCT01369758Not applicableResults posted
- ExAblate UF V2 System for the Treatment of Symptomatic Uterine FibroidsCompletedNCT01285960Not applicableResults posted
- HOME Study: Hysteroscopic Office Myomectomy EvaluationCompletedNCT01152112Not applicableResults posted
- Safety Study of ExAblate for the Treatment of Uterine FibroidsCompletedNCT01142791Not applicableResults posted
- Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine FibroidsTerminatedNCT01069120Phase 3Results posted
- Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum ToxinCompletedNCT00971620Phase 2Results posted
- An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 ExtTerminatedNCT00958893Phase 2Results posted
- Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003CompletedNCT00958334Phase 2Results posted
- Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine FibroidsCompletedNCT00897897Not applicableResults posted
- Post Market Study for an Adhesion Barrier Following Laparoscopic MyomectomyCompletedNCT00891657Not applicableResults posted
- Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine FibroidsCompletedNCT00874029Not applicableResults posted
- Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00853567Phase 3Results posted
- Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine FibroidsCompletedNCT00837161Phase 1/2Results posted
- Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine FibroidsTerminatedNCT00785356Phase 3Results posted
- PGL4001 Versus Placebo in Uterine MyomasCompletedNCT00755755Phase 3Results posted
- PGL4001 Versus GnRH-agonist in Uterine MyomasCompletedNCT00740831Phase 3Results posted
- Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine FibroidsTerminatedNCT00737282Phase 3Results posted
- Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00735553Phase 3Results posted
- Hysteroscopic Cryomyolysis for the Treatment of Submucosal LeiomyomataCompletedNCT00731341Not applicableResults posted
- ExAblate Treatment of Uterine Fibroids for Fertility EnhancementTerminatedNCT00730886Not applicableResults posted
- Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine FibroidsTerminatedNCT00702702Phase 3Results posted
- Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine FibroidsTerminatedNCT00683917Phase 2Results posted
- A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)CompletedNCT00628901Phase 4Results posted
- Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related BleedingTerminatedNCT00496080Not applicableResults posted
- MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced SonicationCompletedNCT00365989Phase 3Results posted
- Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914CompletedNCT00290251Phase 2Results posted
- Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine FibroidsCompletedNCT00131365Not applicableResults posted
- Bleeding Control Methods in Open MyomectomyCompletedNCT07553091Not applicable